Nanoencapsulation of ABT-737 and camptothecin enhances their clinical potential through synergistic antitumor effects and reduction of systemic toxicity
Daniela Schmid(Queen's University Belfast), Christopher J. Scott(Queen's University Belfast)
Cited by 55
Related Papers
Anti-DLL4 VNAR targeted nanoparticles for targeting of both tumour and tumour associated vasculature
|Nanoscale|2020|19
Controlled coupling of an ultrapotent auristatin warhead to cetuximab yields a next-generation antibody-drug conjugate for EGFR-targeted therapy of KRAS mutant pancreatic cancer
|British Journal of Cancer|2020|19